Cyclin B3 drives mitotic progression and fidelity in cancer cells
Researchers demonstrate that cyclin B3 interacts with CDK1 and CDK2 to ensure timely mitotic progression and proper chromosome alignment in cancer cells.
Researchers demonstrate that cyclin B3 interacts with CDK1 and CDK2 to ensure timely mitotic progression and proper chromosome alignment in cancer cells.